Skip to content

Valneva

  • Über uns
    Über uns Förderung von Impfstoffen für ein besseres Leben Mehr lesen
    • Unsere Strategie
    • Unsere Expertise im Bereich der Reisegesundheit
    • Unsere Verpflichtungen in den Bereichen Umwelt, Soziales und Unternehmensführung
    • Unser Team
  • Produkte
    Produkte Fokus auf Impfstoffe für Infektionskrankheiten mit hohem ungedecktem Bedarf Mehr lesen
    • Produkte
    • Marketing und Vertrieb
    • Produktion und Dienstleistungen
  • F&E
    F&E Wir haben uns der Innovation in der Impfstoffforschung und -entwicklung verpflichtet. Mehr lesen
    • Pipeline
    • Lyme Borreliose – VLA15
    • Chikungunya – VLA1553
    • Shigellen – S4V2
    • Zika – VLA1601
    • Erweiterte Zugriffsrichtlinie
    • Wissenschaftliche Publikationen
    • Von Forschern initiierte Studien
  • Investors
    Investors Mehr lesen
    • Veranstaltungen
    • Präsentationen des Unternehmens
    • Finanzberichte
    • SEC-Einreichungen
    • Pressemeldungen
    • Unternehmensführung
      • Unternehmensführung
      • Corporate Compliance und Ethik
    • Vorgeschriebene Informationen
    • Aktieninformation
      • Aktienkurs
      • Analysten
      • Aktionärsstruktur
      • Delisting von der Wiener Börse
    • Hauptversammlungen
      • 25. Juni 2025 Kombinierte Hauptversammlung
      • Archiv Hauptversammlungen
    • Videos und Webcasts
    • Häufig gestellte Fragen
    • Kontakt
  • Media
    Media Pressemeldungen, Aktuelles und Ressourcen für Medien Mehr lesen
    • Pressemeldungen
    • Stories
    • Ressourcen für Medien
    • Kontakte für Medien und Investoren
  • Karriere
  • EN
  • FR
  • DE
Search

Documents in Connection with the Cross-Border Merger

Joint merger plan dated December 16, 2012

Amendment to the merger plan dated January 18, 2013­

Pro forma income statement (non-GAAP):

Audited financial statements and status reports as well as corporate governance reports, to the extent that these had to be prepared in accordance with the legal regulations, of Intercell AG for the last three financial years­

  • 2012 Annual Report
  • 2012 Statutory Financial Statements
  • 2011 Annual Report
  • 2011 Statutory Financial Statements
  • 2010 Annual Report
  • 2010 Statutory Financial Statements

Interim financial statements of Intercell AG as of June 30, 2012­

Interim financial statements of Vivalis SA as of June 30, 2012 ­

Merger report of the Management Board of Intercell AG (in German) ­

Merger report of the Management Board of Vivalis SA (in French)­

Audit report of the merger auditor appointed by the Supervisory Board of Intercell AG, Grant Thornton

Audit report of the SE conversion auditor, Grant Thornton appointed upon application of Vivalis SA by the president of the Commercial Court in Angers (in French)

Merger report of the Supervisory Board of Intercell AG

Audit report of Deloitte as auditor of Vivalis SA on the issuance of the Preferred Shares (in French)

Notice merger according to Section 10 para 4 Austrian Capital Markets­

Notice merger pursuant to section 19 of the Act on the Statute for a European Company

Valneva

  • Über uns
  • Produkte
  • F&E
  • Investors
  • Media
  • Karriere
Weitere Websites
  • Valneva Canada
  • Valneva UK
  • Valneva Austria
  • Valneva USA
  • Valneva Nordic
  • Valneva France
Kontakt
© 2025 Valneva SE. Alle Rechte vorbehalten.
  • Rechtliche Hinweise
  • Cookie Policy
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • 1907-00-VLA-002 | 11-JUL-2019
We use cookies to improve the functionality and user experience of the website and to analyse the traffic. You can find detailed information in our Datenschutzerklärung.
ACCEPT REJECT CHANGE MY PREFERENCES
Privacy & Cookies Policy

Your privacy is important to us

Cookies are very small text files that are stored on your computer when you visit a website. We use cookies for a variety of purposes and to enhance your online experience on our website (for example, to remember your account login details).

You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website.

More information

For any queries in relation to our policy on cookies and your choices, please contact us.

To find out more, please visit our Cookies Policy.
Strictly necessary cookies
Always Enabled
These cookies are essential to provide you with services available through our website and to enable you to use certain features of our website. Without these cookies, we cannot provide you certain services on our website.
Tracking and performance cookies
These cookies are used to collect information to analyze the traffic to our website and how visitors are using our website. For example, these cookies may track things such as how long you spend on the website or the pages you visit which helps us to understand how we can improve our website site for you. The information collected through these tracking and performance cookies do not identify any individual visitor.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT